Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3795467 | 0.82 | CA2 (0.39) | ALDH1A1L3MBTL1 | |
| SCHEMBL1827433 | 0.79 | KDM4E (0.39) | KDM4ETSHRTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL383637 | 0.77 | TSHR (0.38) | KDM4ETSHRTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL1827215 | 0.77 | TSHR (0.38) | KDM4ETSHRTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL1826316 | 0.77 | TSHR (0.38) | KDM4ETSHRTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL1824726 | 0.77 | TSHR (0.38) | KDM4ETSHRTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL1829776 | 0.77 | TSHR (0.38) | KDM4ETSHRTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL5485456 | 0.77 | TSHR (0.38) | KDM4ETSHRTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL1826686 | 0.77 | TSHR (0.38) | KDM4ETSHRTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL5484308 | 0.77 | TSHR (0.38) | KDM4ETSHRTDP1ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842199-B2 | Proton conducting titanate, polymer nano-composite membrane including the same, and fuel cell adopting the polymer nano-composite membrane | SAMSUNG SDI CO., LTD. (KR) | 2010-11-30 | — | — | US | claimed |
| US-20070053826-A1 | Proton conducting titanate, polymer nano-composite membrane including the same, and fuel cell adopting the polymer nano-composite membrane | SAMSUNG SDI CO., LTD. (KR) | 2007-03-08 | — | — | US | claimed |
| US-20110193068-A1 | Composite film, flexible substrate including the composite film, and organic light emitting device including the flexible substrate | SAMSUNG DISPLAY CO., LTD. (KR) | 2011-08-11 | — | — | US | disclosed |
| US-7842199-B2 | Proton conducting titanate, polymer nano-composite membrane including the same, and fuel cell adopting the polymer nano-composite membrane | SAMSUNG SDI CO., LTD. (KR) | 2010-11-30 | — | — | US | disclosed |
| US-20070053826-A1 | Proton conducting titanate, polymer nano-composite membrane including the same, and fuel cell adopting the polymer nano-composite membrane | SAMSUNG SDI CO., LTD. (KR) | 2007-03-08 | — | — | US | disclosed |
| US-20060269816-A1 | Proton conducting inorganic material, polymer nano-composite membrane including the same, and fuel cell adopting the polymer nano-composite membrane | SAMSUNG SDI CO., LTD. (KR) | 2006-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070053826-A1 | Proton conducting titanate, polymer nano-composite membrane including the same, and fuel cell adopting the polymer nano-composite membrane | TTN, CD4, HCN4 | KDM4E 1557/4885TSHR 1746/4885TDP1 4097/4885 |
| US-20110193068-A1 | Composite film, flexible substrate including the composite film, and organic light emitting device including the flexible substrate | MSN, ELOVL6, FTO | KDM4E 2184/4885TSHR 4417/4885TDP1 3613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.